Quarterly report [Sections 13 or 15(d)]

Consolidated Statements of Equity (Parenthetical)

v3.26.3
Consolidated Statements of Equity (Parenthetical) - shares
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Statement of Stockholders' Equity [Abstract]        
Beginning balance (in shares) 113,411,882 112,929,288 113,210,642 112,703,460
Conversion of common units to common shares (in shares) 5,908 22,292 5,908 33,881
Share-based compensation issuance, net of redemptions (in shares) 2,603 (1,221) 203,843 213,018
Ending balance (in shares) 113,420,393 112,950,359 113,420,393 112,950,359